Document – Pharmaceutical Benefits Advisory Committee (PBAC) meeting for medicines relating to AstraZeneca
FOI number:
982-1819
FOI release date:
Publication type:
Report
Audience:
General public
Description:
This document related to the Minutes for the November 2018 Pharmaceutical Benefits Advisory Committee (PBAC) meeting for medicines use in non-small cell lung cancer in relation to AstraZeneca.